16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-amines.

University of Kansas
Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.

University of Ljubljana
Identification of Inhibitors of NOD1-Induced Nuclear Factor-¿B Activation.

TBA
Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic¿-glutamyldiaminopimelic acid derivatives.

University of Kansas
Salutaxel, a Conjugate of Docetaxel and a Muramyl Dipeptide (MDP) Analogue, Acts as Multifunctional Prodrug That Inhibits Tumor Growth and Metastasis.

Shenzhen Salubris Pharmaceuticals Co.
Identification of benzofused five-membered sultams, potent dual NOD1/NOD2 antagonists in vitro and in vivo.

Peking Union Medical College
Structural features and functional activities of benzimidazoles as NOD2 antagonists.

University of Ljubljana
Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy.

Peking Union Medical College
Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.

University of Ljubljana
Modulation of the NOD-like receptors NOD1 and NOD2: A chemist's perspective.

University of Delaware
Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.

Peking Union Medical College
Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

Boehringer Ingelheim International
Heteroaromatic compounds and their use as dopamine D1 ligands

Pfizer
2-Amino-N-pyrimidin-4-ylacetamides as A2A Receptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure-Activity Relationships.

Neuroscience
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.

Conforma Therapeutics
Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.

Glaxosmithkline